SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aronex Pharma (ARNX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lance P. Dykhoff who wrote (19)4/15/1997 9:18:00 PM
From: Tara Cobble   of 320
 
Lance, this is my guess:

ARNX has had 9 reasonably good news releases since November on continued progress with trial and agreements, but the price has slowly slipped down. The NASDAQ and that sector for the most part have been week and I think the brokers who follow ARNX may be talking clients into putting more money into ARNX at these levels. You may want to look into ARNX closely and check out the burn rate vs. cash on hand. If I remember correctly ARNX has a lot of cash and there is always the chance that what goes up, then goes down, and it they make progress then it goes back up again. People and funds may just be doubling down at these levels.

This is only my thoughts and I do not have any facts to back it up nor have I spoken with my broker, so it is only a guess.

I might consider it but I did that on another stock that I own.

Tara
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext